Hosted by Dr. Léorah Freeman, the episode highlights the inspiring work and collaboration between a start-up and academia, bringing together expertise in MS research, neuro-optometry, and optical engineering, to address some of the big unmet needs in MS care: progression independent of relapse (PIRA). Featuring Dr. Christy Sheehy (CEO of C. Light Technologies), Dr. Jacqueline Theis (neuro-optometrist and Chief Medical Officer), and Dr. Ari Green (Professor of Neurology at UCSF), the discussion highlights their project—a study on a novel quantitative oculomotor biomarker based on small retinal eye movements. This biomarker holds the promise of enabling earlier and more precise detection of PIRA.

The conversation delves deeper into the value of investigating eye movements and other biomarkers, emphasizing their importance in tracking disease progression and advancing precise diagnostic tools. Listen now and be inspired by their journey—from starting with academic research to founding a successful startup and building larger collaborations.

Together they have been working to design a solution for transformative advances in the MS field to help patients and their carers.

In this #MovingScience podcast, Prof. Gavin Giovannoni (Blizard Institute, Queen Mary University, London) and Dr. Angeli Mayadev (Swedish Hospital, Seattle) reveal how:

-Adaptive exercise makes movement accessible to everyone.

-High-intensity training and mind-body techniques boost body and mind.

-Tele-rehabilitation and insurance rewards programs keep you motivated.

-You can safely address challenges like heat sensitivity, fatigue, or fear of over-exercising.

Even  fun activities like walking and  standing at a soccer, baseball, or basketball game count as movement and boost your health. Let’s get moving—together!

Tune in to this podcast and move toward a healthier, happier you!

Discover how the rise of the #BrainEconomy is creating brighter futures for individuals and societies. Join Prof. Dr. Gavin Giovannoni and Dr. Harris Eyre as they discuss why it matters and how education, health, and labor systems must evolve together—powered by global contributions like those of the @World Economic Forum. Watch now and be part of the movement toward a more brain-positive world!

We’re kicking off with a powerful truth: if your brain isn’t healthy, you aren’t either.

In our first episode, Prof. Gavin Giovannoni Prof. Gavin Giovannoni speaks with Stephanie Kramer from the European Brain Council about the impact of #BrainHealth on our lives, our systems, and our societies. Don't miss their insights on lifelong brain health, and why investing in brain research, optimizing care, and policy matters now more than ever.

#Brain #MovingSciencePodcast #Podcast #Roche

Welcome to the final episode of our first series of the Moving Science podcast! In this special episode we will be changing roles: Prof. Dr. Gavin Giovannoni, the main host of the series, will be joining us as the guest, and PD Dr. Vera Zingler from Roche, who has been initiating and leading the podcast project, will be our interviewer for the first time.

Together, they will reflect on the journey so far. Join us as both speakers delve into the complexities of MS and its management and take a look at what's coming next in our exciting new series on Brain Health.

Don't miss this final episode of Series 1, and stay tuned for our upcoming discussions!

Host: Prof. Olga Ciccarelli, UCL Queen Square Institute of Neurology and Neuroinflammation in London

Speaker: Prof. Massimo Filippi, Vita-Salute San Raffaele University in Milan, Italy

This new episode will be interesting to anyone keen to learn about the current standards of care and recent advancements in the field of MRI and MS, including the recent revision of the McDonald criteria, AI-driven and automated MRI, and an outlook to the future. 

Join us as our speakers discuss the need for a "cultural switch" in MS – a shift already prominent in other disease areas such as Alzheimer's and oncological diseases. This change aims to enhance our understanding of MS pathophysiology and emphasizes acting on biomarker findings for early diagnosis and treatment to prevent disease progression.

 Tune in to gain valuable insights and stay updated in the field.

Join our continued discussion with Prof. Gavin Giovannoni and the panel as they delve deeper into current and future applications of NfL and other blood-based biomarkers.The panel explores key aspects of integrating NfL into medical practice, ranging from consistent assay methods for longitudinal data interpretation to accounting for comorbidities. They also address challenges when interpreting discrepancies and discuss access issues in different healthcare systems.Additionally, the experts examine the combination of NfL with other biomarkers such as GFAP and Neurofilament heavy chain in multivariate panels, assessing how these combinations can enhance diagnostic and prognostic value across different sub-populations, including pediatric patients and those with progressive courses of MS.Looking to the future, they imagine a world where people with MS can monitor their biomarker levels at home and explore the potential of blood-based biomarkers for screening and serial monitoring of individuals at risk for various neurological conditions.Immerse yourself in the recent developments and understand the emerging impact of fluid biomarkers in healthcare.

Join Prof. Gavin Giovannoni and a distinguished panel of international experts – Prof. Dr. Tanuja Chitnis, Dr. Sharmilee Gnanapavan, and Dr. Ahmed Obeidat – for a highly educational and thought-provoking podcast. Rich with expert insights and engaging discussions, it offers a comprehensive exploration of the clinical value of NfL in current MS care and the evolving role of fluid biomarkers in the future of medical practice.

The panel shares state-of-the-art knowledge about NfL and discusses experiences from the daily clinical routine, highlighting how NfL provides an additional window for more frequent monitoring of disease activity in people with MS. They also explain how combining NfL with other fluid biomarkers, clinical outcomes, and MRI findings can enhance patient monitoring and improve prognostication.

Tune in to enhance your understanding and stay at the forefront of MS care advancements.

Are you curious about how Artificial Intelligence is revolutionizing neurology healthcare? In the latest episode of the Moving Science podcast, Dr. Agne Straukiene and Prof. Dr. Heinz Wiendl explore the powerful impact of AI on education in healthcare, with a special focus on MultipleSclerosis.

Tune in to learn how AI is reshaping how patients and healthcare professionals access, understand, and apply medical knowledge, enhancing decision-making and paving the way for new treatments.

From advanced information management to cutting-edge AI tools, they break down real-life examples that showcase the incredible potential AI brings to medical practice. Plus, they share their vision for the future of neurology and address the crucial ethical questions that come with these advancements.

Are you curious about how Artificial Intelligence is revolutionizing neurology healthcare? In the latest episode of the Moving Science podcast, Dr. Agne Straukiene and Prof. Dr. Heinz Wiendl explore the powerful impact of AI on education in healthcare, with a special focus on MultipleSclerosis.

Tune in to learn how AI is reshaping how patients and healthcare professionals access, understand, and apply medical knowledge, enhancing decision-making and paving the way for new treatments.

From advanced information management to cutting-edge AI tools, they break down real-life examples that showcase the incredible potential AI brings to medical practice. Plus, they share their vision for the future of neurology and address the crucial ethical questions that come with these advancements.